نمایش پرونده ساده آیتم

dc.contributor.authorPashoutan Sarvar, D
dc.contributor.authorShamsasenjan, K
dc.contributor.authorAkbarzadehlaleh, P
dc.date.accessioned2018-08-26T05:36:32Z
dc.date.available2018-08-26T05:36:32Z
dc.date.issued2016
dc.identifier10.15171/apb.2016.041
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/39564
dc.description.abstractMesenchymal stromal/stem cells (MSCs) are involved in tissue homeostasis through direct cell-to-cell interaction, as well as secretion of soluble factors. Exosomes are the sort of soluble biological mediators that obtained from MSCs cultured media in vitro. MSC-derived exosomes (MSC-DEs) which produced under physiological or pathological conditions are central mediators of intercellular communications by conveying proteins, lipids, mRNAs, siRNA, ribosomal RNAs and miRNAs to the neighbor or distant cells. MSC-DEs have been tested in various disease models, and the results have revealed that their functions are similar to those of MSCs. They have the supportive functions in organisms such as repairing tissue damages, suppressing inflammatory responses, and modulating the immune system. MSC-DEs are of great interest in the scope of regenerative medicine because of their unique capacity to the regeneration of the damaged tissues, and the present paper aims to introduce MSC-DEs as a novel hope in cell-free therapy.
dc.language.isoEnglish
dc.relation.ispartofAdvanced pharmaceutical bulletin
dc.titleMesenchymal Stem Cell-Derived Exosomes: New Opportunity in Cell-Free Therapy.
dc.typearticle
dc.citation.volume6
dc.citation.issue3
dc.citation.spage293
dc.citation.epage299
dc.citation.indexPubmed
dc.identifier.DOIhttps://doi.org/10.15171/apb.2016.041


فایلهای درون آیتم

فایلهاسایزفرمتنمایش

هیچ فایل مرتبطی وجود ندارد

این آیتم در مجموعه های زیر مشاهده می شود

نمایش پرونده ساده آیتم